As CEO, Mark leads on the strategy and delivery of all aspects of IBioIC’s activities. He also leads the commercial strategy to enable IBioIC to engage, collaborate with and support business, academia and Government.
Mark joined IBioIC from CPI where he was Business Development Director for the £38M National Biologics Manufacturing Centre in Darlington.
Prior to this he was the Medicines Manufacturing Specialist at the Knowledge Transfer Network (KTN), Technical Director for Medicines at the previous HealthTech and Medicines KTN and worked for seven years developing the growth of bioprocessing across the UK via bioProcessUK. Mark has also worked in bioprocess R&D, manufacturing and consultancy.